4.6 Review

Candida albicans biofilms: building a heterogeneous, drug-tolerant environment

Journal

CURRENT OPINION IN MICROBIOLOGY
Volume 16, Issue 4, Pages 398-403

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2013.03.007

Keywords

-

Categories

Funding

  1. Agence Nationale de Is Recherche [ANR-08-MIE-033-01, CANDICOL ANR-10-01]
  2. French Government's Investissement d'Avenir program
  3. Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]
  4. European Commission (FINSysB) [PITN-GA-2008-214004]
  5. Fondation pour la Recherche Medicate [DEA20080713005]

Ask authors/readers for more resources

Fungi are able to form biofilms on medical implants, causing serious infections. A better understanding of fungal biofilm formation is necessary to develop tools for detection or prevention and to identify new antifungal strategies. This review explores recent advances in the characterization at the molecular level of fungal biofilms, especially those formed by the yeast Candida albicans: the identification of complex transcriptional networks that control their formation; the pivotal role of the extracellular matrix in biofilm antifungal tolerance; and the knowledge gained on the physiology of biofilm cells and heterogeneity within these communities. These findings may help develop new, targeted therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available